1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Nephro Care India Limited

Nephro Care India Limited

NNSE:NEPHROCARE
83.00
INR
-2.95
(-3.43%)
0.87EPS
59.28P/E
853.17MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.11
2.08
10.37
16.52
30.12
51.38
26.59
Basic EPS, GAAP
0.05
-0.01
1.18
2.68
2.38
2.04
0.87
Free Cash Flow per Basic Share
0.09
-1.38
2.28
-1.44
-14.38
-3.39
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.01
0.3
1.48
9.11
32.44
34.49
34.49
Tangible Book Value per Share
0.01
0.3
1.48
9.11
32.43
34.42
34.42
Basic Weighted Avg Shares
16
16
16
16
15
16
16
Sales/Revenue/Turnover
18
34
171
272
460
847
434
Operating Margin (%)
7.76
0.41
16.89
21.81
7.41
-1.95
-6.94
Depreciation Expense
- -
1
8
5
25
51
30
Net Income, GAAP
1
- -
19
44
36
34
14
Effective Tax Rate (%)
24.77
5,000
28.35
27.65
24.65
27.97
23.34
Profit Margin (%)
4.86
-0.29
11.36
16.2
7.91
3.98
3.28
Working Capital
- -
-6
-5
50
142
155
155
LT Debt
6
25
24
- -
- -
- -
- -
Total Equity
- -
5
24
150
535
569
569
Return on Invested Capital (%)
- -
-36.81
46.1
37.96
7.38
-2.14
-4.11
Return on Capital (%)
- -
-39.3
50.61
44.3
10.65
6.31
2.58
Return on Common Equity (%)
- -
-3.84
132.46
50.52
10.62
6.11
2.54

Capital Structure

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
2,355
1,789
853

Working Capital

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
259
- -
308
Cash, Cash Equivalents & STI
141
- -
165
Accounts Receivable, Net
46
- -
60
Inventories
22
- -
23
Total Current Liabilities
106
- -
153
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
874.47%
6.39%
Free Cash Flow
- -
-247.49%
-74.54%
Net Income, GAAP
- -
-3,985.86%
-7.42%
Sales/Revenue/Turnover
- -
139.84%
84.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
75
272
2025
- -
- -
- -
- -
460
2026
- -
- -
227
207
847

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.61
2.68
2025
- -
- -
- -
- -
2.38
2026
- -
- -
0.26
0.61
2.04

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Pratim Sengupta
Sector
Health services
Industry
Medical/Nursing services
Address
Kolkata India
IPO Date
Jul 5, 2024
Website
nephrocareindia.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Nephro Care India Ltd. operates within the healthcare sector, concentrating on comprehensive services for kidney-related conditions. Established in 2014 by Dr. Pratim Sengupta, the company is headquartered in Kolkata, India, and offers a full spectrum of renal insufficiency treatments. Its services encompass hemodialysis, peritoneal dialysis, kidney transplant care, conservative nephrology, and associated diagnostic and support offerings. The company emphasizes a 360-degree holistic care approach, integrating medical, lifestyle, and nutritional support for patients. Nephro Care India has expanded its reach, having recently completed an Initial Public Offering (IPO) in July 2024 and listed on the NSE Emerge platform. The firm is actively growing its infrastructure, with plans to establish additional comprehensive kidney care centers across India and has inaugurated a 100-bedded multi-specialty hospital in Kolkata.